<DOC>
	<DOCNO>NCT00764270</DOCNO>
	<brief_summary>The purpose study see dietary supplement , R-alpha lipoic acid , able reduce risk factor people document heart disease increase level inflammation .</brief_summary>
	<brief_title>The Role R-Alpha Lipoic Acid Treatment Atherosclerotic Vascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Documented congestive heart disease ( CHD ) ( define least one significant coronary stenosis &gt; 50 % angiography , history document myocardial infarction ) Not diagnose unstable angina , uncontrolled hypertension , heart failure , recent myocardial infarction ( within last six month ) Not take insulin oral hypoglycemic agent , antiinflammatory drug aspirin , hormone replacement therapy On stable dos four week prior entry lipidlowering therapy ( statin ) , aspirin , angiotensinconverting enzyme inhibitor blood pressure medication . P No tobacco use within 3 month study No laboratory evidence renal , hepatic , hematological abnormality Not currently take vitamin antioxidant supplement , include Ralpha lipoic acid , except standard multivitamin/mineral supplement contain Daily Value ( DV ) vitamins mineral ; Elevated level urinary plasma F2isoprostanes Elevated plasma level hsCRP</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>lipoic acid</keyword>
	<keyword>thioctic acid</keyword>
	<keyword>triglyceride</keyword>
	<keyword>overweight</keyword>
	<keyword>obesity</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>inflammation</keyword>
</DOC>